Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1.

Abstract The discovery of a series of phenylalanine derived CCR3 antagonists is reported. Parallel, solution-phase library synthesis has been utilized to delineate the structure–activity relationship leading to the synthesis of highly potent, CCR3-selective antagonists.